Does SIMVASTATIN Cause Product substitution issue? 105 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Product substitution issue have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.4% of all adverse event reports for SIMVASTATIN.
105
Reports of Product substitution issue with SIMVASTATIN
0.4%
of all SIMVASTATIN reports
1
Deaths
23
Hospitalizations
How Dangerous Is Product substitution issue From SIMVASTATIN?
Of the 105 reports, 1 (1.0%) resulted in death, 23 (21.9%) required hospitalization, and 2 (1.9%) were considered life-threatening.
Is Product substitution issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Product substitution issue?
AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832)
BUPROPION (1,578)
METHYLPHENIDATE (1,408)
CLONAZEPAM (1,288)
LAMOTRIGINE (979)
ALBUTEROL (864)
LEVOTHYROXINE (803)
DULOXETINE (766)
ESTRADIOL (692)
SERTRALINE (636)
Which SIMVASTATIN Alternatives Have Lower Product substitution issue Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS